Skip to main content
Top

Impact of Collateral on Emergency Department Length of Stay in College-Aged Patients

  • 01-09-2020
  • Original Paper
Published in:

Abstract

This study evaluated the efficacy of a collaborative intervention between hospitals and universities to decrease the length of stay (LOS) in the Emergency Department (ED) for college students. The hypothesis was that university collateral would decrease LOS in the ED. A retrospective chart review was performed for 834 consults in patients aged 18–25 regarding presence of collateral, disposition, and LOS. Of those hospitalized, LOS in the ED was 15.7 h for students with collateral, 14.6 h for students without collateral, and 19.5 h for unenrolled peers. There was a statistically significant difference in LOS for patients hospitalized in enrolled versus unenrolled patients (t = 2.17, p = 0.031). Of those discharged home, students with collateral, students without collateral, and unenrolled peers spent 9.7 h, 11.6 h, and 13.6 h in the ED respectively. LOS of enrolled versus unenrolled patients discharged home trended towards significance (t = 1.80, p = 0.073), but no significance was found in relation to collateral (t = 1.21,p = 0.23). This study found that college students had decreased LOS in the ED regardless of collateral when compared to unenrolled peers.
Title
Impact of Collateral on Emergency Department Length of Stay in College-Aged Patients
Authors
Varsha Radhakrishnan
Sumita Sharma
Christopher Baca
John Torous
Elizabeth Dunn
Publication date
01-09-2020
Publisher
Springer US
Published in
Psychiatric Quarterly / Issue 3/2020
Print ISSN: 0033-2720
Electronic ISSN: 1573-6709
DOI
https://doi.org/10.1007/s11126-020-09741-6
This content is only visible if you are logged in and have the appropriate permissions.

Keynote webinar | Spotlight on functional neurological disorder

FND perplexes and frustrates patients and physicians alike. Limited knowledge and insufficient awareness delays diagnosis and treatment, and many patients feel misunderstood and stigmatized. How can you recognize FND and what are the treatment options?

Prof. Mark Edwards
Watch now
Video

Keynote webinar | Spotlight on addressing alcohol-associated liver disease

On-demand video coming soon

The global burden of ALD is growing and compounded by frequent late-stage diagnosis and undertreatment. Get the latest insights into patient risk and identification, treatment and management, and the arrival of MetALD.

Prof. Helena Cortez-Pinto
Prof. Mark Thursz
Dr. Juan Pablo Arab
Notify me
Image Credits
Human brain illustration/© (M) CHRISTOPH BURGSTEDT / SCIENCE PHOTO LIBRARY / Getty Images, Abstract low poly wireframe illustration of the liver/© (M) Yevhen Lahunov / iStock / Getty Images Plus